Join to View Full Profile
45 Francis StAsb IIBoston, MA 02115
Phone+1 617-525-7697
Fax+1 617-525-6348
Dr. Kibel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Minimally Invasive Urologic Surgery, 1997 - 1999
Mass General Brigham/Brigham and Women's Hospital/Harvard Medical SchoolResidency, Urology, 1993 - 1997- Mass General Brigham/Brigham and Women's HospitalResidency, Surgery, 1991 - 1993
Weill Cornell MedicineClass of 1991
Certifications & Licensure
MA State Medical License 1992 - 2027
ME State Medical License 2020 - 2027
RI State Medical License 2021 - 2026
NH State Medical License 2023 - 2025
MO State Medical License 1999 - 2012
MD State Medical License 1997 - 2000
American Board of Urology Urology
Awards, Honors, & Recognition
- Boston Magazine Castle Connolly, 2012-2023
- America's Top Doctors Castle Connolly, 2009-2023
- America's Top Doctors for Cancer Castle Connolly, 2005-2023
Clinical Trials
- Observation or Radical Treatment in Patients With Prostate Cancer Start of enrollment: 2007 Dec 06
- Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancer.Fu Gui, Baishan Jiang, Jie Jiang, Zhixiang He, Takuya Tsujino
Science Advances. 2025-04-25 - 1 citationsFeasibility of MRI-Guided Transperineal Implantation of Microdevices for Drug Delivery and Response Assessment in Prostate Cancer.Quinn Rainer, Kemal Tuncali, Wooseok Ahn, Fanni Viktoria Santa, Michelle Hirsch
Journal of Magnetic Resonance Imaging. 2025-04-11 - Identifying Patients at Risk of Early Lethal Prostate Cancer by Integrating Family History, Polygenic Risk Score, Rare Variants in DNA Repair Genes, and Lifestyle Fact...Zhizhu Zhang, Yiwen Zhang, Konrad H Stopsack, Adam S Kibel, Edward L Giovannucci
European Urology Oncology. 2025-04-04
Journal Articles
- Geographic Distribution of Racial Differences in Prostate Cancer MortalityDavid F Friedlander, Kerry L Kilbridge, Paul L Nguyen, Toni K Choueiri, Adam S Kibel, Quoc-Dien Trinh, JAMA Network Open
- miR-218 Expressed in Endothelial Progenitor Cells Contributes to the Development and Repair of the Kidney MicrovasculatureSteven L Chang, Graeme Steele, Adam S Kibel, Andrew M Siedlecki, The American Journal of Pathology
- Neoadjuvant Androgen Deprivation Therapy Prior to Radical Prostatectomy: Recent Trends in Utilization and Association with Postoperative Surgical Margin StatusPaul L Nguyen, Adam S Kibel, Mani Menon, Sean A Fletcher, Toni K Choueiri, Annals of Surgical Oncology
Authored Content
- Comparative Effectiveness of Robot-Assisted vs. Open Radical Cystectomy☆☆☆December 2017
Press Mentions
What’s the Difference Between a Prostate Exam and a Colonoscopy?November 26th, 2024- At High Risk of Prostate Cancer? Here’s How to Lower Your OddsJuly 14th, 2022
- Healthy Lifestyle May Offset Genetic Risk of Prostate CancerJuly 11th, 2022
- Join now to see all
Grant Support
- Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancerBRIGHAM AND WOMEN'S HOSPITAL2023–2028
- Pilot study of an implantable microdevice to test multiple drug responses in prostate cancer patientsBRIGHAM AND WOMEN'S HOSPITAL2019–2025
- NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer CareDANA-FARBER CANCER INST2019–2025
- The Role of PARP2 in Prostate CancerDepartment of Defense2017–2020
- A selective Androgen Receptor Modulator for Symptom Management in Prostate CancerNational Cancer Center2015–2020
- NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care for ALLIANCE Cooperative Oncology ConsortiumNational Cancer Institute2014–2019
- Dana Farber-Harvard Cancer Center Specialized Program of Research Excellence (SPORE) in Prostate CancerNational Cancer Institute2013–2018
- A multilevel approach to energy balance and cancer across the lifecourseNational Cancer Institute2011–2017
- Hypogonadism and Pain Perception in Androgen-deprived Men with Prostate CancerNational Cancer Institute2013–2016
- Cell Cycle Variants And Metastatic Prostate Cancer RiskNational Cancer Institute2005–2009
- Identification Of A 12p Prostate Tumor Suppressor GeneNational Cancer Institute2001–2006
- Genetic Risk Profiling In Metastatic Prostate CarcinomaNational Cancer Institute2003–2004
Committees
- Vice Chair, Castration-resistant Prostate Cancer Guidelines Panel, AUA 2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
